clinical characteristics of h-mds
Published 2 years ago • 93 plays • Length 3:11Download video MP4
Download video MP3
Similar videos
-
4:42
a practical approach to the classification of mds
-
5:38
the molecular and clinical classifications of mds
-
1:41
an overview of the mds diagnosis pathway
-
0:35
mds: the role of the multidisciplinary team
-
3:56
the genetic landscape of mds and impact on treatment
-
5:14
prognostic value of the updated icc and who classifications for mds
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
1:34
perspectives on the management of low and high-risk mds
-
7:54
patient/caregiver stories - living with mds
-
4:28
understanding myelodysplastic syndromes (mds)
-
4:48
managing and treating mds
-
1:32
the importance of cytogenetics and molecular profiling for accurate aml/mds diagnosis
-
3:36
the genetic landscape of mds: how this is improving & impacting the development of therapies
-
1:57
safety and efficacy of sx-682 in hma failure mds
-
1:16
state of the art: mds
-
1:41
using cytogenetics to improve the diagnosis and prognosis of mds & to predict response to treatment
-
3:06
the role of chronic inflammation in lower-risk mds and future therapeutic strategies
-
2:49
the role of the immune system in the pathophysiology of mds
-
3:57
validation of the ipss-m risk stratification system in mds
-
1:24
mm-6 study: in-class transition to a regimen of ixazomib, lenalidomide, & dexamethasone for myeloma
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
1:22
managing cytopenias following jak inhibitor treatment & achieving true disease modification in mf